StockData
Cullinan Therapeutics, Inc. logo

Cullinan Therapeutics, Inc. (CGEM) stock

CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$9.01−0.27 (-2.86%)

Close on Nov 18, 2026Market cap $579.84MP/E –Yield –

Cullinan Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cullinan Therapeutics's pe ratio was 8.5× on Jul 31, 2023.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jul 31, 20238.5×+3.7
2022Dec 30, 20224.8×–

More Cullinan Therapeutics figures

See a number that looks wrong?